These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35545361)

  • 1. Cell HE staining smears and paired cell paraffin sections in detection of epithelial growth factor receptor gene of pleural fluid specimens.
    Hou F; Qi C; Lu Y; Li F; Hao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):35-44. PubMed ID: 35545361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of EGFR Mutations Detected in Pleural Effusion and Its 
Clinical Significance in 132 Patients with Advanced Non-small Cell Lung Cancer: 
A Retrospective Study in A Single Center].
    Lu T; Li Q; Li L; Yang K; Zhou D; Gao J; Chen M; Xu Y; Zhong W; Wang M; Liang Z; Zhao J
    Zhongguo Fei Ai Za Zhi; 2020 Dec; 23(12):1059-1065. PubMed ID: 33357312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.
    Lozano MD; Zulueta JJ; Echeveste JI; Gúrpide A; Seijo LM; Martín-Algarra S; Del Barrio A; Pio R; Idoate MA; Labiano T; Perez-Gracia JL
    Oncologist; 2011; 16(6):877-85. PubMed ID: 21572125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Cancer.
    Liu CH; Chang SJ; Tsai MJ; Yang SF
    Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):701-706. PubMed ID: 37807651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.
    Xu H; Sun W; Zhang G; Cheng Y
    J BUON; 2015; 20(1):142-5. PubMed ID: 25778309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of the detection of
    Zhu Y; Zhu F; Wang L; Zhai X; Shan X
    Indian J Pathol Microbiol; 2021; 64(1):107-110. PubMed ID: 33433418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the Relationship Between the Quality of Small Biopsy Specimens of 
Non-small Cell Lung Cancer and the Mutation Rate of EGFR Gene].
    Li Y; Gu Y; Jiang J
    Zhongguo Fei Ai Za Zhi; 2021 May; 24(5):331-337. PubMed ID: 34034456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients.
    Song Z; Wang W; Li M; Liu J; Zhang Y
    Lung Cancer; 2019 Oct; 136():23-29. PubMed ID: 31421258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting outcomes of EGFR-targeted therapy in non-small cell lung cancer patients using pleural effusions samples and peptide nucleic acid probe assay.
    Wang MC; Wang CL; Chen TL; Chang JW; Lu JJ; Chang PY; Chiou CC
    Clin Chem Lab Med; 2017 Oct; 55(12):1979-1986. PubMed ID: 28787267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients.
    Wu W; Cao Z; Zhang W; Zhang L; Hou L; Wu C
    Diagn Pathol; 2020 Jan; 15(1):9. PubMed ID: 32005253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR and K-ras mutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens.
    Gallegos Ruiz MI; Floor K; Rijmen F; Grünberg K; Rodriguez JA; Giaccone G
    Cell Oncol; 2007; 29(3):257-64. PubMed ID: 17452778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the Idylla
    De Luca C; Conticelli F; Leone A; Gragnano G; Salatiello M; Galasso P; Pisapia P; Grillo LR; Iaccarino A; Vigliar E; Bellevicine C; Malapelle U; Troncone G
    J Clin Pathol; 2019 Sep; 72(9):609-614. PubMed ID: 31110050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Epidermal Growth Factor Receptor Gene Mutations Identified Using Pleural Effusion and Primary Tumor Tissue Samples in Non-Small Cell Lung Cancer.
    Liu N; Sun RZ; Du J; Dong QZ; Fan CF; Li QC; Wang EH; Liu Y
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):e44-e51. PubMed ID: 28800007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Whiting P; van Asselt T; Ramaekers B; Armstrong N; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2014 May; 18(32):1-166. PubMed ID: 24827857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of EGFR mutation in supernatant, cell pellets of pleural effusion and tumor tissues from non-small cell lung cancer patients by high resolution melting analysis and sequencing.
    Lin J; Gu Y; Du R; Deng M; Lu Y; Ding Y
    Int J Clin Exp Pathol; 2014; 7(12):8813-22. PubMed ID: 25674250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer.
    Jian G; Songwen Z; Ling Z; Qinfang D; Jie Z; Liang T; Caicun Z
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1341-7. PubMed ID: 20155428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of ARMS and direct sequencing for EGFR mutation analysis and tyrosine kinase inhibitors treatment prediction in body fluid samples of non-small-cell lung cancer patients.
    Liu Y; Liu B; Li XY; Li JJ; Qin HF; Tang CH; Guo WF; Hu HX; Li S; Chen CJ; Liu B; Gao HJ; Liu XQ
    J Exp Clin Cancer Res; 2011 Dec; 30(1):111. PubMed ID: 22142557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of EGFR gene mutations in 100 non-small cell lung cancer clinical samples by a real-time polymerase chain reaction method using amplification refractory mutation system specific primers and Taqman fluorescence probes].
    Zhao J; Zhao J; Zhao X; Chen W; Zhong W; Zhang L; Li L; Wang M
    Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):25-32. PubMed ID: 23327870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.
    Ellison G; Zhu G; Moulis A; Dearden S; Speake G; McCormack R
    J Clin Pathol; 2013 Feb; 66(2):79-89. PubMed ID: 23172555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients.
    Li X; Liu Y; Shi W; Xu H; Hu H; Dong Z; Zhu G; Sun Y; Liu B; Gao H; Tang C; Liu X
    Clin Chim Acta; 2017 Aug; 471():177-184. PubMed ID: 28602964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.